Using an economic model of diabetes to evaluate prevention and care strategies in Australia

Health Affairs

Volumn 27, Issue 1, 2008, Pages 256-268

  Colagiuri, Stephen ^a   Walker, Agnes E ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; AUSTRALIA; COST BENEFIT ANALYSIS; DIABETES MELLITUS; ECONOMICS; EVALUATION; HEALTH CARE; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; LIFESTYLE MODIFICATION; MASS SCREENING; MIDDLE AGED; MODEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; QUALITY ADJUSTED LIFE YEAR; SCREENING; SEX DIFFERENCE; STATISTICAL MODEL;

AGE FACTORS; AGED; AUSTRALIA; COST-BENEFIT ANALYSIS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; HUMANS; MASS SCREENING; MIDDLE AGED; MODELS, ECONOMETRIC; OBESITY; PRACTICE GUIDELINES AS TOPIC; QUALITY-ADJUSTED LIFE YEARS; SEX FACTORS;

EID: 38849207861     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.27.1.256     Document Type: Article

References (33)

1. S. Wild et al., "Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030," Diabetes Care 27, no. 5 (2004): 1047-1053.
2. International Diabetes Federation, "Diabetes Facts and Figures," http://www.idf.org/home/index.cfm?node=6 (accessed 9 October 2007).
3. Australian Institute of Health and Welfare, Australia's Health 2006 (Canberra: AIHW, 2006).
4. S. Colagiuri, R. Colagiuri, and J. Ward, The National Diabetes Strategy and Implementation Plan (Canberra: Diabetes Australia, 1998).
5. S. Colagiuri et al., Evidence Based Guideline for Case Detection and Diagnosis of Type 2 Diabetes, December 2001, http://www.diabetesaustralia. com.au/_lib/doc_pdf/NEBG/CD/Part3-CaseDetection-311201.pdf (accessed 8 November 2007).
6. D.W. Dunstan et al., "The Rising Prevalence of Diabetes and Impaired Glucose Tolerance: The Australian Diabetes, Obesity, and Lifestyle Study," Diabetes Care 25, no. 5 (2002): 829-834; and the related AusDiab database.
7. S. Begg et al., The Burden of Disease and Injury in Australia 2003, AIHW Cat. no. PHE 82 (Canberra: AIHW, 2007);
8. C. Murray and A. Lopez, eds., The Global Burden of Disease (Boston: Harvard University Press, 1996);
9. and C. Mathers, T. Vos, and C. Stevenson, The Burden of Disease and Injury in Australia (Canberra: AIHW, 1999).
10. R. O'Connor, Measuring Quality of Life in Health (London: Churchill Livingstone, Elsevier, 2004).
11. A. Walker, "Multiple Chronic Diseases and Quality of Life: Patterns Emerging froma Large National Sample, Australia," Chronic Illness (forthcoming);
12. and A. Walker and S. Colagiuri, "Cost-Benefit Model Systems of Chronic Diseases in Australia: To Assess and Rank Prevention and Treatment Options" (Paper presented at International Microsimulation Association conference, Vienna, Austria, 20-22 August 2007).
13. A. Walker, S. Colagiuri, and M. McLennan, "Cost-Benefit Model of Diabetes Prevention and Care: Model Construction, Assumptions, and Validation," Technical Paper no. 28, https://guard.canberra.edu.au/natsem/ index.php?mode=download&file_id=569 (accessed 9 October 2007).
14. Australian Bureau of Statistics, "Projections of the Populations of Australia, States, and Territories: 1995-2051," Cat. no. 3222.0 (Canberra: Australian Government Publishing Service, 1996). For the diabetes model, the bureau's "No overseas migration" scenario was chosen, which simplified the tracking of cohorts.
15. See Walker and Colagiuri, "Cost-Benefit Model Systems."
16. ABS, National Health Survey 2001, Summary of Results, Cat. no. 4364.0 (Canberra: ABS, 2002);
17. and ABS, National Health Survey 2004-05, Summary of Results, Cat. no. 4364.0 (Canberra: ABS, 2006).
18. D. McCarty et al., "The Rise and Rise of Diabetes in Australia" (Canberra: Diabetes Australia, 1996).
19. J. Tuomilehto et al., "Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance," New England Journal of Medicine 344, no. 18 (2001): 1343-1350;
20. and W.C. Knowler et al., "Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin," New England Journal of Medicine 346, no. 6 (2002): 393-403.
21. J. Lindström et al., "Sustained Reduction in the Incidence of Type 2 Diabetes by Lifestyle Intervention: Follow-up of the Finnish Diabetes Prevention Study," Lancet 368, no. 9548 (2006): 1673-1679.
22. S. Colagiuri et al., "Screening for Type 2 Diabetes and Impaired Glucose Metabolism: The Australian Experience," Diabetes Care 27, no. 2 (2004): 367-371.
23. Colagiuri et al., "Evidence Based Guidelines."
24. S. Colagiuri et al., "Are Lower Fasting Plasma Glucose Levels at Diagnosis of Type 2 Diabetes Associated with Improved Outcomes? U.K. Prospective Diabetes Study 61," Diabetes Care 25, no. 8 (2002): 1410-1417.
25. Walker et al., "Cost-Benefit Model of Diabetes."
26. L. Brown et al., "Funding of High Cost Biotechnology and Other Innovative Targeted Therapies under the Pharmaceutical Benefits Scheme," NATSEM Position Paper for Collaborative Forum, Sydney, Australia, 7 March 2002;
27. A. Kennedy et al., "The Effectiveness and Cost Effectiveness of a National Lay-Led Self Care Support Programme for Patients with Long-Term Conditions: A Pragmatic Randomised Controlled Trial," Journal of Epidemiology and Community Health 61, no. 3 (2007): 254-261;
28. and C. Griffiths et al., "How Effective Are Expert Patient (Lay Led) Education Programmes for Chronic Disease?" British Medical Journal 334, no. 7606 (2007): 1254-1256.
29. R. Eastman et al., "Model of Complications of NIDDM, I. Model Construction and Assumptions," Diabetes Care 20, no. 5 (1997): 725-734;
30. R. Eastman et al., "Model of Complications of NIDDM, II. Analysis of the Health Benefits and Cost-Effectiveness of Treating NIDDM with the Goal of Normoglycemia," Diabetes Care 20, no. 5 (1997): 735-744;
31. and P. Clarke et al., "A Model to Estimate the Lifetime Health Outcomes of Patients with Type 2 Diabetes: The United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)," Diabetologia 47, no. 10 (2004): 1747-1759.
32. Dunstan et al., "The Rising Prevalence of Diabetes"; and S. Colagiuri et al., DiabCo$t Australia: Assessing the Burden of Diabetes in Australia (Canberra: Diabetes Australia, 2004).
33. Walker, "Multiple Chronic Diseases."